STDN Standard Nuclear, Inc.
Industrial Inorganic Chemicals · NYSE · SEC CIK 2086716 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA—
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets4.9%
Debt / equity0.00x
Current ratio30.56x
Interest coverage—
Cash quality & payout
Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $5.96M | $4.74M | — | $875,299 | $552,939 | — |
| Cost of revenue | $4.16M | $1.55M | — | $2.35M | $1.18M | — |
| Gross profit | $1.81M | $3.18M | — | -$1.48M | -$629,750 | — |
| R&D expense | $1.42M | $1.96M | — | $0 | $0 | — |
| SG&A expense | $15.46M | $5.52M | — | $1.77M | $1.01M | — |
| Operating income | -$15.07M | -$4.30M | — | -$3.24M | -$1.64M | — |
| Pretax income | -$13.06M | -$3.42M | — | -$3.24M | -$1.63M | — |
| Income tax | $0 | $0 | — | $0 | $0 | — |
| Net income | -$13.06M | -$3.42M | -$7.71M | -$3.24M | -$1.63M | -$8.29M |
| EBITDA | -$15.07M | -$3.90M | — | -$3.24M | — | — |
| EPS (basic) | -0.10 | -0.12 | — | -0.12 | -0.06 | — |
| EPS (diluted) | -0.10 | -0.12 | — | -0.12 | -0.06 | — |
| Dividends declared per share | 0.00 | 0.00 | — | 0.00 | 0.00 | — |
| Weighted avg. shares (diluted) | 134.92M | 28.00M | — | 28.00M | 28.00M | — |
| Balance sheet | ||||||
| Cash & equivalents | $223.14M | $102.19M | — | — | — | — |
| Receivables | $10.61M | — | — | — | — | — |
| Current assets | $237.88M | $113.10M | — | — | — | — |
| PP&E, net | $46.80M | $31.38M | — | — | — | — |
| Total assets | $287.23M | $146.95M | — | — | — | — |
| Current liabilities | $7.79M | $8.75M | — | — | — | — |
| Total liabilities | $14.22M | $9.54M | — | — | — | — |
| Shareholders' equity | $273.01M | -$77.59M | -$76.32M | -$68.51M | -$66.05M | -$64.60M |
| Shares outstanding | 0 | 0 | — | — | — | — |
| Cash flow statement | ||||||
| Operating cash flow | -$5.63M | — | — | -$2.65M | — | — |
| Capital expenditure | $14.79M | — | — | $4.39M | — | — |
| Free cash flow | -$20.42M | — | — | -$7.03M | — | — |
| Investing cash flow | -$15.78M | — | — | -$4.39M | — | — |
| Financing cash flow | $142.37M | — | — | $70.00M | — | — |
| Depreciation & amortization | $0 | $400,000 | — | $0 | — | — |
| Stock-based compensation | $10.28M | $2.15M | — | $790,657 | $175,702 | — |
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.